Evaluation of T-cell infiltrating lymphocytes vs. Th2 in triple negative breast cancers (TNBC)

被引:0
|
作者
Brousse, Susie
Godey, Florence
Laffont, Elodie
Tas, Patrick
Campillo-Gimenez, Boris
Lavoue, Vincent
Le Gallo, Matthieu
机构
关键词
D O I
10.1158/1538-7445.SABCS22-P2-11-23
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P2-11-23
引用
收藏
页数:2
相关论文
共 50 条
  • [21] T2-weighted magnetic resonance images of triple negative breast cancer with high tumor infiltrating lymphocytes
    Inagaki, M.
    Ota, D.
    Tsuji, M.
    Nishi, T.
    Kato, T.
    Kobayashi, Y.
    Mori, M.
    Fukuuchi, A.
    BREAST, 2017, 32 : S55 - S55
  • [22] Prognostic Assessment of Stromal and Non-Stromal Tumor-Infiltrating Lymphocytes (TILs) in Triple-Negative Breast Cancer (TNBC)
    Ghosh, Toshi
    Goetz, Matthew
    Leon-Ferre, Roberto A.
    Liu, Heshan
    Polley, Mei-Yin C.
    Ingle, James
    Cafourek, Victoria L.
    Hillman, David W.
    Carter, Jodi
    Visscher, Daniel
    LABORATORY INVESTIGATION, 2018, 98 : 61 - 62
  • [23] The role of CCN5 in regulation of tumor-infiltrating lymphocytes ( TILS) in triple-negative breast cancer (TNBC) cells
    Biswas, Upasana
    Kambhampati, Anjali
    Haideri, Noor
    De, Archana
    Upadhyay, Sunil
    Banerjee, Snigdha
    Banerjee, Sushanta
    CANCER RESEARCH, 2024, 84 (06)
  • [24] Clinico-pathological relationship between androgen receptor (AR) and tumor infiltrating lymphocytes (TILs) in triple negative breast cancer (TNBC)
    Elghazawy, H.
    Alorabi, M. O.
    Helal, T.
    Aref, A.
    Kelany, M.
    Abdallah, L. A. Eid
    Sayed, F.
    Ali, D.
    Zaki, D.
    Ahmed, M.
    ANNALS OF ONCOLOGY, 2019, 30 : 22 - +
  • [25] Prognostic Assessment of Stromal and Non-Stromal Tumor-Infiltrating Lymphocytes (TILs) in Triple-Negative Breast Cancer (TNBC)
    Ghosh, Toshi
    Goetz, Matthew
    Leon-Ferre, Roberto A.
    Liu, Heshan
    Polley, Mei-Yin C.
    Ingle, James
    Cafourek, Victoria L.
    Hillman, David W.
    Carter, Jodi
    Visscher, Daniel
    MODERN PATHOLOGY, 2018, 31 : 61 - 62
  • [26] Tumor cell recognition by γδ T lymphocytes T-cell receptor vs. NK-cell receptors
    Correia, Daniel V.
    Lopes, Antonio
    Silva-Santos, Bruno
    ONCOIMMUNOLOGY, 2013, 2 (01):
  • [27] Comparison of mutations and protein expression in potentially actionable targets in 5500 triple negative vs. non-triple negative breast cancers
    O'Shaughnessy, J. A.
    Gatalica, Z.
    Kimbrough, J. M.
    Millis, S. Z.
    CANCER RESEARCH, 2013, 73
  • [28] The immunomodulatory (IM) signature enhances prediction of pathologic complete response (pCR) to neoadjuvant therapy (NAT) in triple negative breast cancers (TNBC) with moderate stromal tumour infiltrating lymphocytes (sTIL)
    Abuhadra, N.
    Sun, R.
    Litton, J. K.
    Rauch, G.
    Thompson, A. M.
    Lim, B.
    Adrada, B.
    Mittendorf, E.
    Damodaran, S.
    Pitpitan, R.
    Arun, B.
    White, J.
    Ravenberg, E.
    Santiago, L.
    Sahin, A.
    Murthy, R.
    Ueno, N. T.
    Ibrahim, N.
    Moulder, S.
    Huo, L.
    ANNALS OF ONCOLOGY, 2020, 31 : S49 - S49
  • [29] Generation of T cell subsets with polarized function (Th2/Ts vs. Th1/Tc)
    Leskovar, P
    Schmidmaier, R
    BONE MARROW TRANSPLANTATION, 1999, 23 : S36 - S37
  • [30] T-cell subsets (Th1 versus Th2)
    Romagnani, S
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2000, 85 (01) : 9 - 18